GlassScriptPhysician profile
Manuel Jose Perez
NPI 1083627814
$8,683.52
in general payments reported to CMS, 2019-2025
40 companies · $603 in 2025
The $603 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,379 · 2020: $308 · 2021: $672 · 2022: $2,140 · 2023: $2,955 · 2024: $627 · 2025: $603.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,669 · Travel and Lodging: $1,515.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,669.23 |
| Travel and Lodging | $1,515.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $2,381.44 | 2020-2024 | Axonics, Bulkamid |
| Teleflex LLC | $2,154.73 | 2020-2025 | Urolift, Barrigel |
| Neotract INC. | $1,258.41 | 2019-2020 | |
| Procept Biorobotics Corporation | $233.57 | 2023-2024 | Aquabeam System, Aquabeam Robotic System |
| Abbvie INC. | $222.40 | 2022-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $211.59 | 2022-2025 | |
| Astellas Pharma US INC | $210.47 | 2019-2023 | Myrbetriq |
| Boston Scientific Corporation | $206.69 | 2021-2025 | Spaceoar Vue System - 10ml, Axonics |
| Myovant Sciences INC. | $202.73 | 2021-2022 | |
| Kowa Pharmaceuticals America, INC. | $181.28 | 2022-2023 | Seglentis |
| Calyxo, INC. | $127.38 | 2025 | Cvac Aspiration System |
| Accord Healthcare, INC. | $121.69 | 2022-2025 | |
| Pfizer INC. | $112.86 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $94.39 | 2020-2022 | |
| Sumitomo Pharma America, INC. | $90.69 | 2024-2025 | Orgovyx, Gemtesa |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Manuel Perez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.